This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Reference
- Biological “markers” for endogenous depression.Arch Gen Psychiatry. 1984; 41: 1080-1085
- Neuroendocrine abnormalities in bulimia.Am J Psychiatry. 1983; 140: 559-563
- Hypothalamic-pituitary-adrenal axis hyperactivity in bulimia.Psychiatry Res. 1983; 8: 111-117
- Dexamethasone Suppression Test in bulimia.Biol Psychiatry. 1986; 21: 328-332
- DST and TRH-ST in mood disorder subtypes.Am J Psychiatry. 1987; (in press).
- The Dexamethasone Suppression Test in bulimia.Am J Psychiatry. 1985; 142: 1375-1376
- The Dexamethasone Test in patients with bulimia.J Clin Psychiatry. 1984; 45: 508-511
- Prediction of post-dexamethasone cortisol levels by serum sodium levels in patients with major depression.Am J Psychiatry. 1986; 143: 81-84
- The validity of the Dexamethasone Suppression Test as a marker for endogenous depression.Arch Gen Psychiatry. 1986; 43: 347-355
Article info
Publication history
Received in revised form:
November 8,
1986
Received:
September 25,
1986
The authors acknowledge the assistance of Julie Lunzy.Footnotes
Supported in part by an Ohio Department of Mental Health grant (85–168) and by the Bremer Foundation.
Identification
Copyright
© 1987 Society of Biological Psychiatry. Published by Elsevier Inc.
